145 related articles for article (PubMed ID: 15831157)
1. Evidence of endothelial dysfunction in patients with functionally univentricular physiology before completion of the Fontan operation.
Binotto MA; Maeda NY; Lopes AA
Cardiol Young; 2005 Feb; 15(1):26-30. PubMed ID: 15831157
[TBL] [Abstract][Full Text] [Related]
2. Altered endothelial function following the Fontan procedure.
Binotto MA; Maeda NY; Lopes AA
Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358
[TBL] [Abstract][Full Text] [Related]
3. [Plasminogen activator inhibitor (PAI-1) and markers of endothelial dysfunction in patients with diabetes mellitus].
Galajda P; Martinka E; Baláz D; Stasko J; Kerný J; Planková E; Mokán M; Kubisz P
Vnitr Lek; 1997 Nov; 43(11):744-7. PubMed ID: 9650506
[TBL] [Abstract][Full Text] [Related]
4. von Willebrand factor antigen, tissue-type plasminogen activator antigen, and risk of death in human immunodeficiency virus 1-related clinical disease: independent prognostic relevance of tissue-type plasminogen activator.
Schved JF; Gris JC; Arnaud A; Martinez P; Sanchez N; Wautier JL; Sarlat C
J Lab Clin Med; 1992 Sep; 120(3):411-9. PubMed ID: 1517688
[TBL] [Abstract][Full Text] [Related]
5. Endothelial marker proteins in hyperhomocysteinemia.
de Jong SC; Stehouwer CD; van den Berg M; Vischer UM; Rauwerda JA; Emeis JJ
Thromb Haemost; 1997 Nov; 78(5):1332-7. PubMed ID: 9408014
[TBL] [Abstract][Full Text] [Related]
6. von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis.
Blann AD; Dobrotova M; Kubisz P; McCollum CN
Thromb Haemost; 1995 Aug; 74(2):626-30. PubMed ID: 8584997
[TBL] [Abstract][Full Text] [Related]
7. Type 2 diabetes: assessment of endothelial lesion and fibrinolytic system markers.
Soares AL; Sousa Mde O; Dusse LM; Fernandes AP; Lasmar MC; Novelli BA; Lages Gde F; Carvalho Md
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):395-9. PubMed ID: 17581312
[TBL] [Abstract][Full Text] [Related]
8. Endothelial cell activation and blood coagulation in critically ill patients with lung injury.
Wenzel C; Kofler J; Locker GJ; Laczika K; Quehenberger P; Frass M; Knöbl P
Wien Klin Wochenschr; 2002 Oct; 114(19-20):853-8. PubMed ID: 12503477
[TBL] [Abstract][Full Text] [Related]
9. Endothelial haemostatic markers in members of families with familial combined hyperlipidemia.
Karásek D; Vaverková H; Halenka M; Slavík L; Novotný D
Thromb Res; 2009; 123(3):466-75. PubMed ID: 18417194
[TBL] [Abstract][Full Text] [Related]
10. [Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis].
Bobkova IN; Kozlovskaia LV; Rameeva AS; Varshavskiĭ VA; Golitsyna EP
Ter Arkh; 2007; 79(6):10-5. PubMed ID: 17684960
[TBL] [Abstract][Full Text] [Related]
11. [Molecular markers of endothelial dysfunction in acute ischemic stroke].
Szegedi N; May Z; Ováry C; Skopál J; Nagy Z
Ideggyogy Sz; 2002 Mar; 55(3-4):102-8. PubMed ID: 12122979
[TBL] [Abstract][Full Text] [Related]
12. [Thrombomodulin, von Willebrand factor and tissue plasminogen activator in the blood plasma of obese women and men].
Rość D; Drewniak W; Kinasz-Rózycka I; Kulwas A; Michalski A
Pol Merkur Lekarski; 2003 Dec; 15(90):518-20. PubMed ID: 15058251
[TBL] [Abstract][Full Text] [Related]
13. Angiogenic and prothrombotic markers in extensive slow-flow vascular malformations: implications for antiangiogenic/antithrombotic strategies.
Redondo P; Aguado L; Marquina M; Paramo JA; Sierra A; Sánchez-Ibarrola A; Martínez-Cuesta A; Cabrera J
Br J Dermatol; 2010 Feb; 162(2):350-6. PubMed ID: 19769632
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals.
Stam F; Schalkwijk CG; van Guldener C; ter Wee PM; Stehouwer CD
Nephrol Dial Transplant; 2006 Mar; 21(3):677-82. PubMed ID: 16330467
[TBL] [Abstract][Full Text] [Related]
15. [Endothelial dysfunction in a family with familial combined hyperlipidemia].
Karásek D; Vaverková H; Hutyra M; Halenka M; Novotnyý D; Budíková M; Slavík L
Vnitr Lek; 2003 Aug; 49(8):623-9. PubMed ID: 14518086
[TBL] [Abstract][Full Text] [Related]
16. Markers of endothelial dysfunction in children with idiopathic nephrotic syndrome.
Tkaczyk M; Czupryniak A; Owczarek D; Lukamowicz J; Nowicki M
Am J Nephrol; 2008; 28(2):197-202. PubMed ID: 17962717
[TBL] [Abstract][Full Text] [Related]
17. Plasma thrombomodulin in orthotopic liver transplantation.
Boutiere B; Arnoux D; Boffa MC; Samson D; Le Treut YP; Sampol J
Transplantation; 1994 Dec; 58(12):1352-5. PubMed ID: 7809928
[TBL] [Abstract][Full Text] [Related]
18. Kynurenines and oxidative status are independently associated with thrombomodulin and von Willebrand factor levels in patients with end-stage renal disease.
Pawlak K; Domaniewski T; Mysliwiec M; Pawlak D
Thromb Res; 2009 Sep; 124(4):452-7. PubMed ID: 19477487
[TBL] [Abstract][Full Text] [Related]
19. Disturbances of coagulation in neonates with functionally univentricular physiology prior to the first stage of surgical reconstruction.
Hakacova N; Laluhova-Striezencova Z; Zahorec M
Cardiol Young; 2008 Aug; 18(4):397-401. PubMed ID: 18559135
[TBL] [Abstract][Full Text] [Related]
20. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients.
Iorio A; Federici MO; Mourvaki E; Ferolla P; Piroddi M; Stabile A; Timi A; Celleno R; Benedetti MM
Thromb Haemost; 2007 Sep; 98(3):635-41. PubMed ID: 17849053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]